Stephen Sullivan

Stephen J.
Sullivan is the founder of Cro Advisors LLC, founded in 2010.
Current jobs include Independent Director at Interpace Biosciences, Inc. since 2020, Director at Transnetyx, Inc. since 2018, and Executive Advisor at Thompson Street Capital Managers LLC.
Former jobs include Chairman & Chief Executive Officer at Xenometrix, Inc. from 1996 to 1999; President, Chief Executive Officer & Director at Harlan Laboratories, Inc. from 2006 to 2010; Chairman at Bioreclamation-IVT Holdings LLC from 2013 to 2016; Chairman at H2O Clinical LLC; Non-Executive Chairman at BioIVT LLC from 2013 to 2016; Chairman at Microbiology Research Associates, Inc. from 2015 to 2020; Chairman at Firma Clinical Research LLC from 2016 to 2018; Chairman at Pharma Start LLC; Director at PHT Corp.
from 2013 to 2015; Director at The Emmes Co. LLC from 2019 to 2022; Director at Molecular Imaging, Inc. from 2019 to 2020; Director at Accel Clinical Services LLC from 2015 to 2017; VP & General Manager-Global Diagnostic at Abbott Laboratories; Head-Marketing at Baxter International, Inc.; Senior Vice President at Labcorp Drug Development, Inc. from 1999 to 2006; Commander at United States Marine Corps; Principal at Lyphomed, Inc.; Principal at Dart & Kraft, Inc.; President at Covance Central Laboratories, Inc. from 1999 to 2006; Senior Lecturer at Kellogg School of Management in 1997; Senior Vice President at Covance, Inc. Education includes an MBA from Rutgers State University of New Jersey and undergraduate studies at the University of Dayton.